BNP Paribas Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Buy
33,098
+2,008
+6% +$93.7K ﹤0.01% 1102
2025
Q4
$921K Buy
31,090
+3,387
+12% +$92K ﹤0.01% 1181
2025
Q3
$712K Sell
27,703
-66,213
-71% -$1.85M ﹤0.01% 708
2025
Q2
$2.59M Sell
93,916
-27,811
-23% -$732K 0.01% 676
2025
Q1
$3.46M Buy
121,727
+48,529
+66% +$1.72M 0.01% 609
2024
Q4
$3.04M Sell
73,198
-12,275
-14% -$587K 0.01% 645
2024
Q3
$5.71M Buy
85,473
+29,177
+52% +$2.68M 0.01% 519
2024
Q2
$6.68M Sell
56,296
-37,172
-40% -$4.7M 0.02% 484
2024
Q1
$9.96M Sell
93,468
-205,609
-69% -$20.7M 0.03% 430
2023
Q4
$29.7M Buy
299,077
+242,781
+431% +$20.4M 0.08% 248
2023
Q3
$5.82M Buy
56,296
+12,131
+27% +$1.35M 0.02% 490
2023
Q2
$5.37M Buy
44,165
+1,100
+3% +$147K 0.02% 505
2023
Q1
$6.61M Sell
43,065
-35,971
-46% -$5.93M 0.02% 483
2022
Q4
$14.2M Sell
79,036
-16,009
-17% -$2.62M 0.05% 370
2022
Q3
$11.2M Sell
95,045
-34,234
-26% -$5.19M 0.04% 392
2022
Q2
$18.5M Sell
129,279
-84,138
-39% -$12M 0.07% 295
2022
Q1
$36.8M Buy
213,417
+87,758
+70% +$14.8M 0.13% 196
2021
Q4
$31.9M Buy
125,659
+51,353
+69% +$15M 0.11% 234
2021
Q3
$28.6M Buy
74,306
+51,308
+223% +$18.9M 0.11% 228
2021
Q2
$5.41M Buy
22,998
+16,668
+263% +$2.98M 0.02% 534
2021
Q1
$829K Buy
6,330
+170
+3% +$24.6K ﹤0.01% 739
2020
Q4
$644K Sell
6,160
-634
-9% -$64.1K ﹤0.01% 742
2020
Q3
$481K Sell
6,794
-40
-0.6% -$2.79K ﹤0.01% 745
2020
Q2
$439K Buy
+6,834
New +$374K ﹤0.01% 708

Other funds holding MRNA